NSC |
Compound |
Enrichment |
Correlation |
NSC 704639 |
Null |
0.00662388971299138 |
0.25816854 |
NSC 709447 |
Null |
0.00662388971299138 |
0.18991856 |
NSC 735846 |
Null |
0.00662388971299138 |
0.49245471 |
NSC 746035 |
2-4-[(5-2,6-dimethoxy-4-[5-(3,4,5-trimethoxyphenyl)-4,5-dihydro-3-isoxazolyl]phenoxypentyl)oxy]-3-methoxyphenyl-1,2,3,4-tetrahydro-4-quinazolinone |
0.00662388971299138 |
0.068061973 |
NSC 754109 |
ethyl 8-(3-methoxybenzyl)-5,8-dihydro-4H-isoxazolo[4,5-g]indole-7-carboxylate |
0.00662388971299138 |
0.1651888 |
NSC 92915 |
ANTINEOPLASTIC-92915 |
0.00662388971299138 |
0.41587219 |
NSC 9598 |
3-(Dimethylamino)-7-(methylimino)-3H-phenothiazine hydrochloride |
0.00662388971299138 |
0.26548034 |
NSC 669793 |
Null |
0.0072542482863368 |
-0.28270564 |
NSC 678994 |
2-Butenedioic acid, 2-(6-aminopurin-9-yl)-, diethylester, (E)- |
0.0072542482863368 |
0.42084828 |
NSC 684909 |
2,6-Pyrimidinediamine, 4-chloro-5-[(4-chlorophenyl)azo]- N(6)-[[1-(hydroxymethyl)-3-(phenylmethoxy)cyclobutyl] methyl]-, (Isomer A)-, stereoisomer of NSC-684910 |
0.0072542482863368 |
0.27447477 |